Literature DB >> 24189421

Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver.

Daisuke Aibara1, Kimihiko Matsusue, Kohei Matsuo, Soichi Takiguchi, Frank J Gonzalez, Shigeru Yamano.   

Abstract

Fat-specific protein 27 gene (FSP27), isolated by screening for genes specifically expressed in fully differentiated mouse adipocytes, belongs to the cell death-inducing DNA fragmentation factor, alpha subunit-like effector family. FSP27 is induced in not only adipose tissue but also the liver of ob/ob mice, and it promotes the development of fatty liver. The FSP27 gene is expressed in a fatty liver-specific manner and is not detected in the normal mouse liver. FSP27 expression is directly regulated by the induction of the hepatic peroxisome proliferator-activated receptor γ (PPARγ) in ob/ob fatty liver. In the present study, expression of hepatic FSP27 mRNA was determined in non-genetic fatty liver models. The FSP27 gene was markedly induced in the high-fat- or methionine- and choline-deficient (MCD) diet-induced fatty liver, but it was not elevated in alcohol-induced fatty liver. Interestingly, the induction of FSP27 mRNA due to the MCD diet was independent of PPARγ levels and completely absent in the liver from PPARγ-null mice. These results suggest that FSP27 mRNA expression in the liver depends on the etiology of fatty liver.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24189421      PMCID: PMC7667495          DOI: 10.1248/bpb.b13-00351

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  31 in total

1.  JNK1 but not JNK2 promotes the development of steatohepatitis in mice.

Authors:  Jörn M Schattenberg; Rajat Singh; Yongjun Wang; Jay H Lefkowitch; Raina M Rigoli; Philipp E Scherer; Mark J Czaja
Journal:  Hepatology       Date:  2006-01       Impact factor: 17.425

2.  Activators of the nuclear receptor PPARgamma enhance colon polyp formation.

Authors:  E Saez; P Tontonoz; M C Nelson; J G Alvarez; U T Ming; S M Baird; V A Thomazy; R M Evans
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

3.  Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.

Authors:  A M Lefebvre; I Chen; P Desreumaux; J Najib; J C Fruchart; K Geboes; M Briggs; R Heyman; J Auwerx
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

Review 4.  Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?

Authors:  K J Moore; M L Fitzgerald; M W Freeman
Journal:  Curr Opin Lipidol       Date:  2001-10       Impact factor: 4.776

Review 5.  Animal models of nonalcoholic fatty liver disease.

Authors:  Lionel Hebbard; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

Review 6.  Role of lipid droplet proteins in liver steatosis.

Authors:  Toshikatsu Okumura
Journal:  J Physiol Biochem       Date:  2011-08-17       Impact factor: 4.158

7.  Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27.

Authors:  Rachel J Roth Flach; Hui Qin; Lei Zhang; Anton M Bennett
Journal:  J Biol Chem       Date:  2011-04-26       Impact factor: 5.157

8.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

Authors:  S A Kliewer; J M Lenhard; T M Willson; I Patel; D C Morris; J M Lehmann
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

9.  Functional analysis of FSP27 protein regions for lipid droplet localization, caspase-dependent apoptosis, and dimerization with CIDEA.

Authors:  Kun Liu; Shengli Zhou; Ji-Young Kim; Kristin Tillison; David Majors; David Rearick; Jun Ho Lee; Ruby F Fernandez-Boyanapalli; Katherine Barricklow; M Sue Houston; Cynthia M Smas
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10-20       Impact factor: 4.310

10.  Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27.

Authors:  Kimihiko Matsusue; Takashi Kusakabe; Takahiro Noguchi; Shouichi Takiguchi; Toshimitsu Suzuki; Shigeru Yamano; Frank J Gonzalez
Journal:  Cell Metab       Date:  2008-04       Impact factor: 27.287

View more
  9 in total

1.  Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Ann-Hwee Lee
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

2.  The Lipid Droplet Protein Hypoxia-inducible Gene 2 Promotes Hepatic Triglyceride Deposition by Inhibiting Lipolysis.

Authors:  Marina T DiStefano; Laura V Danai; Rachel J Roth Flach; Anil Chawla; David J Pedersen; Adilson Guilherme; Michael P Czech
Journal:  J Biol Chem       Date:  2015-04-28       Impact factor: 5.157

3.  Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.

Authors:  Ming-Jiang Xu; Yan Cai; Hua Wang; José Altamirano; Binxia Chang; Adeline Bertola; Gemma Odena; Jim Lu; Naoki Tanaka; Kimihiko Matsusue; Tsutomu Matsubara; Partha Mukhopadhyay; Shioko Kimura; Pal Pacher; Frank J Gonzalez; Ramon Bataller; Bin Gao
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

4.  CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting- and diet-induced hepatosteatosis.

Authors:  Cédric Langhi; Ángel Baldán
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

5.  Insulin Represses Fasting-Induced Expression of Hepatic Fat-Specific Protein 27.

Authors:  Kohei Matsuo; Kimihiko Matsusue; Daisuke Aibara; Soichi Takiguchi; Frank J Gonzalez; Shigeru Yamano
Journal:  Biol Pharm Bull       Date:  2017       Impact factor: 2.233

Review 6.  Alcohol and fat promote steatohepatitis: a critical role for fat-specific protein 27/CIDEC.

Authors:  Suthat Liangpunsakul; Bin Gao
Journal:  J Investig Med       Date:  2016-06-24       Impact factor: 2.895

7.  Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.

Authors:  Ananthi Rajamoorthi; Noemí Arias; Jeannine Basta; Richard G Lee; Ángel Baldán
Journal:  J Lipid Res       Date:  2017-09-05       Impact factor: 5.922

8.  The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis.

Authors:  Arnaud Sans; Stéphanie Bonnafous; Déborah Rousseau; Stéphanie Patouraux; Clémence M Canivet; Pierre S Leclere; Jeanne Tran-Van-Nhieu; Carmelo Luci; Béatrice Bailly-Maitre; Xu Xu; Ann-Hwee Lee; Kaori Minehira; Rodolphe Anty; Albert Tran; Antonio Iannelli; Philippe Gual
Journal:  Sci Rep       Date:  2019-05-16       Impact factor: 4.379

9.  Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver.

Authors:  Yun-Xia Zhu; Ming-Liang Zhang; Yuan Zhong; Chen Wang; Wei-Ping Jia
Journal:  J Diabetes Res       Date:  2015-12-07       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.